NS038650/NS/NINDS NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
1999	1
2000	2
2003	1
2004	1
2006	2
2007	4
2008	4
2009	3
2010	4
2011	2
2012	1
2013	1
2014	1
2015	2
2016	2
2020	1
2023	1
2024	0

1

Spinal muscular atrophy: development and implementation of potential treatments.

Arnold WD, Burghes AH. Arnold WD, et al. Ann Neurol. 2013 Sep;74(3):348-62. doi: 10.1002/ana.23995. Ann Neurol. 2013. PMID: 23939659 Free PMC article. Review.

2

Evaluation of the orally bioavailable 4-phenylbutyrate-tethered trichostatin A analogue AR42 in models of spinal muscular atrophy.

Lumpkin CJ, Harris AW, Connell AJ, Kirk RW, Whiting JA, Saieva L, Pellizzoni L, Burghes AHM, Butchbach MER. Lumpkin CJ, et al. Sci Rep. 2023 Jun 26;13(1):10374. doi: 10.1038/s41598-023-37496-0. Sci Rep. 2023. PMID: 37365234 Free PMC article.

3

Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?

Burghes AH, Beattie CE. Burghes AH, et al. Nat Rev Neurosci. 2009 Aug;10(8):597-609. doi: 10.1038/nrn2670. Epub 2009 Jul 8. Nat Rev Neurosci. 2009. PMID: 19584893 Free PMC article. Review.

4

Intragenic complementation of amino and carboxy terminal SMN missense mutations can rescue Smn null mice.

McGovern VL, Kray KM, Arnold WD, Duque SI, Iyer CC, Massoni-Laporte A, Workman E, Patel A, Battle DJ, Burghes AHM. McGovern VL, et al. Hum Mol Genet. 2020 Nov 1;29(21):3493-3503. doi: 10.1093/hmg/ddaa235. Hum Mol Genet. 2020. PMID: 33084884 Free PMC article.

5

Antisense oligonucleotides and spinal muscular atrophy: skipping along.

Burghes AH, McGovern VL. Burghes AH, et al. Genes Dev. 2010 Aug 1;24(15):1574-9. doi: 10.1101/gad.1961710. Genes Dev. 2010. PMID: 20679391 Free PMC article.

6

Embryonic motor axon development in the severe SMA mouse.

McGovern VL, Gavrilina TO, Beattie CE, Burghes AH. McGovern VL, et al. Hum Mol Genet. 2008 Sep 15;17(18):2900-9. doi: 10.1093/hmg/ddn189. Epub 2008 Jul 3. Hum Mol Genet. 2008. PMID: 18603534 Free PMC article.

7

Let all DNA vote: who are the amyotrophic lateral sclerosis candidates?

Burghes AH, Butchbach ME. Burghes AH, et al. Neurology. 2008 Feb 26;70(9):662-3. doi: 10.1212/01.wnl.0000302177.15789.ae. Neurology. 2008. PMID: 18299517 No abstract available.

8

Protective effects of butyrate-based compounds on a mouse model for spinal muscular atrophy.

Butchbach MER, Lumpkin CJ, Harris AW, Saieva L, Edwards JD, Workman E, Simard LR, Pellizzoni L, Burghes AHM. Butchbach MER, et al. Exp Neurol. 2016 May;279:13-26. doi: 10.1016/j.expneurol.2016.02.009. Epub 2016 Feb 15. Exp Neurol. 2016. PMID: 26892876 Free PMC article.

9

The neuromuscular impact of symptomatic SMN restoration in a mouse model of spinal muscular atrophy.

Arnold W, McGovern VL, Sanchez B, Li J, Corlett KM, Kolb SJ, Rutkove SB, Burghes AH. Arnold W, et al. Neurobiol Dis. 2016 Mar;87:116-23. doi: 10.1016/j.nbd.2015.12.014. Epub 2015 Dec 28. Neurobiol Dis. 2016. PMID: 26733414 Free PMC article.

10

Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy.

Azzouz M, Le T, Ralph GS, Walmsley L, Monani UR, Lee DC, Wilkes F, Mitrophanous KA, Kingsman SM, Burghes AH, Mazarakis ND. Azzouz M, et al. J Clin Invest. 2004 Dec;114(12):1726-31. doi: 10.1172/JCI22922. J Clin Invest. 2004. PMID: 15599397 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

28 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year